Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Epiminder (ASX:EPI) Drops 4.4% — Medical-Tech Story Faces Red-Day Test

Epiminder entered the red-screen conversation after the biggest-loser screener showed EPI down -4.4% at A$0.330. That is the sort of move that can pull a small or specialist ASX name from the edge of a watchlist into the centre of the daily debate. The …

Sonal Goyal | 26 June 2026

EZZ Life Science (ASX:EZZ) Falls 3.7% — Wellness Stock Catches Market Chill

EZZ Life Science (ASX:EZZ)entered the red-screen conversation after the biggest-loser screener showed EZZ down -3.7% at A$0.395. That is the sort of move that can pull a small or specialist ASX name from the edge of a watchlist into the centre of the daily …

Sonal Goyal | 26 June 2026

Bioxyne TEMP (ASX:BXNDA) Slides 3.2% —Ticker May Be Temporary, Watchlist Interest Isn’t

The stock appeared on the Australian biggest losers list, with volume of not publicly available and relative volume of not publicly available. Relative volume matters because it hints at whether the session was unusually active or simply a thinly traded decline.

Sonal Goyal | 26 June 2026

Compumedics (ASX:CMP) Drops 4% — Medical Device Stock Gives Traders a Jolt

The stock appeared on the Australian biggest losers list, with volume of 93.52K and relative volume of 1.27. Relative volume matters because it hints at whether the session was unusually active or simply a thinly traded decline.

Sonal Goyal | 26 June 2026

Austco Healthcare (ASX:AHC) Drops 4.2% — Health-Tech Name Trips Losers Radar

Austco Healthcare is a healthcare technology company supplying clinical communication and patient-care systems. Its listed sector context is Health technology / healthcare communications, which helps explain why the market can treat it differently from a bank, retailer or mature dividend payer. Investors are not …

Sonal Goyal | 26 June 2026

Tetratherix (ASX: TTX): Biotech Company Draws Fresh Investor Interest

• Tetratherix (ASX: TTX) gained 2.42% in the latest trading session, bringing the biotechnology company back onto investors' watchlists.

Aditi Sarkar | 26 June 2026

Sleep Technology Back in Focus as SomnoMed (ASX: SOM) Moves Higher

SomnoMed (ASX:SOM) has attracted renewed investor attention after gaining 2.83% during the latest trading session. The move has returned the sleep technology company to investors' watchlists as healthcare innovation continues to attract interest across the ASX.

Aditi Sarkar | 26 June 2026

Biotech Back in Play? Why OncoSil Medical (ASX: OSL) Is Turning Heads on the ASX

OncoSil Medical (ASX: OSL) has returned to investors' watchlists after surging 23.08% during the latest trading session. The sharp rise placed the biotechnology company among the day's strongest-performing ASX stocks and renewed market interest in the healthcare sector.

Aditi Sarkar | 26 June 2026

CT:VQ™ Goes Live in Australia: 4DMedical (ASX:4DX) Advances Global Lung Imaging Expansion

4DMedical Limited (ASX:4DX) has reached a significant regulatory milestone with the approval of its CT:VQ™ imaging software by the Therapeutic Goods Administration (TGA), enabling commercial deployment across Australia. The announcement comes as the company’s shares traded atAUD 4.42, reflecting a 3.28% decline during the …

Sonal Goyal | 26 June 2026

Telix Pharmaceuticals (ASX:TLX): Telix Pharmaceuticals Drops Into Focus as Biotech Investors Watch Growth Valuations

• Telix Pharmaceuticals (ASX:TLX) appears in the large-cap Australian companies screen with a market capitalisation of about 5.34 B AUD in the snapshot used for this article.

Aditi Sarkar | 26 June 2026
Support

Hi! How can we help you today?

Loading…